Nonhematogenic circulating aneuploid cells confer inferior prognosis and therapeutic resistance in gliomas
暂无分享,去创建一个
Ming Li | Mingxiao Li | X. Ren | Shaoping Shen | Haihui Jiang | Chuanwei Yang | Xuzhe Zhao | Q. Zhu | Song Lin | G. Dong | Mingyang Liu | D. Wang | P. Lin | Faliang Gao | Xiaokang Zhang | Yong Cui | Hongyan Chen | A. Y. Lin | F. Gao
[1] Mingxiao Li,et al. Combining hyperintense FLAIR rim and radiological features in identifying IDH mutant 1p/19q non-codeleted lower-grade glioma , 2022, European Radiology.
[2] G. Reifenberger,et al. The 2021 WHO Classification of Tumors of the Central Nervous System: a summary. , 2021, Neuro-oncology.
[3] Ming Li,et al. Combining MGMT promoter pyrosequencing and protein expression to optimize prognosis stratification in glioblastoma , 2021, Cancer Science.
[4] J Zhang,et al. Small Cell Size Circulating Aneuploid Cells as a Biomarker of Prognosis in Resectable Non-Small Cell Lung Cancer , 2021, Frontiers in Oncology.
[5] B. Malomed,et al. A new form of liquid matter: Quantum droplets , 2020, Frontiers of Physics.
[6] P. Lin. Aneuploid Circulating Tumor-Derived Endothelial Cell (CTEC): A Novel Versatile Player in Tumor Neovascularization and Cancer Metastasis , 2020, Cells.
[7] A. Amon,et al. Context is everything: aneuploidy in cancer , 2019, Nature Reviews Genetics.
[8] Laura Keller,et al. Unravelling tumour heterogeneity by single-cell profiling of circulating tumour cells , 2019, Nature Reviews Cancer.
[9] J. Dai,et al. Epithelial-type systemic breast carcinoma cells with a restricted mesenchymal transition are a major source of metastasis , 2019, Science Advances.
[10] B. Engelhardt,et al. PECAM-1 Stabilizes Blood-Brain Barrier Integrity and Favors Paracellular T-Cell Diapedesis Across the Blood-Brain Barrier During Neuroinflammation , 2019, Front. Immunol..
[11] Susan M. Chang,et al. Liquid biopsy in central nervous system metastases: a RANO review and proposals for clinical applications , 2019, Neuro-oncology.
[12] Wei Huang,et al. Supratentorial high-grade astrocytoma with leptomeningeal spread to the fourth ventricle: a lethal dissemination with dismal prognosis , 2019, Journal of Neuro-Oncology.
[13] Z. Storchová,et al. The diverse consequences of aneuploidy , 2019, Nature Cell Biology.
[14] L. Chambless,et al. Cancer Dissemination, Hydrocephalus, and Survival After Cerebral Ventricular Entry During High-Grade Glioma Surgery: A Meta-Analysis , 2018, Neurosurgery.
[15] Zhe Liu,et al. Circulating tumor cells with karyotyping as a novel biomarker for diagnosis and treatment of nasopharyngeal carcinoma , 2018, BMC Cancer.
[16] M. Speicher,et al. Current and future perspectives of liquid biopsies in genomics-driven oncology , 2018, Nature Reviews Genetics.
[17] Lin Zhang,et al. Circulating Glioma Cells Exhibit Stem Cell-like Properties. , 2018, Cancer research.
[18] S. Deweerdt. The genomics of brain cancer , 2018, Nature.
[19] B. Nahed,et al. Blood-based biomarkers for the diagnosis and monitoring of gliomas. , 2018, Neuro-oncology.
[20] L. Shen,et al. Evolutionary Expression of HER2 Conferred by Chromosome Aneuploidy on Circulating Gastric Cancer Cells Contributes to Developing Targeted and Chemotherapeutic Resistance , 2018, Clinical Cancer Research.
[21] A. Idbaih,et al. Liquid Biopsy in Primary Brain Tumors: Looking for Stardust! , 2018, Current Neurology and Neuroscience Reports.
[22] Zhixian Gao,et al. Clinical characteristics associated with the intracranial dissemination of gliomas , 2018, Clinical Neurology and Neurosurgery.
[23] Sean P. Palecek,et al. Directed differentiation of human pluripotent stem cells to blood-brain barrier endothelial cells , 2017, Science Advances.
[24] G. Reifenberger,et al. European Association for Neuro-Oncology (EANO) guideline on the diagnosis and treatment of adult astrocytic and oligodendroglial gliomas. , 2017, The Lancet. Oncology.
[25] F. Oliver,et al. Vasculogenic mimicry signaling revisited: focus on non-vascular VE-cadherin , 2017, Molecular Cancer.
[26] Benjamin M. Ellingson,et al. Modified Criteria for Radiographic Response Assessment in Glioblastoma Clinical Trials , 2017, Neurotherapeutics.
[27] Haihui Jiang,et al. Circulating tumor cell is a common property of brain glioma and promotes the monitoring system , 2016, Oncotarget.
[28] P. Lin. Integrated EpCAM-independent subtraction enrichment and iFISH strategies to detect and classify disseminated and circulating tumors cells , 2015, Clinical and Translational Medicine.
[29] T. Luider,et al. Circulating glioma biomarkers. , 2014, Neuro-oncology.
[30] A. Iafrate,et al. Brain tumor cells in circulation are enriched for mesenchymal gene expression. , 2014, Cancer discovery.
[31] M. Speicher,et al. Hematogenous dissemination of glioblastoma multiforme , 2014, Science Translational Medicine.
[32] L. Shen,et al. Clinical significance of phenotyping and karyotyping of circulating tumor cells in patients with advanced gastric cancer , 2014, Oncotarget.
[33] C. Chapman,et al. Detection of brain tumor cells in the peripheral blood by a telomerase promoter-based assay. , 2014, Cancer research.
[34] D. Friedmann-Morvinski,et al. Dedifferentiation and reprogramming: origins of cancer stem cells , 2014, EMBO reports.
[35] N. Schultz,et al. Cancer cells preferentially lose small chromosomes , 2013, International journal of cancer.
[36] David Pellman,et al. Causes and consequences of aneuploidy in cancer , 2012, Nature Reviews Genetics.
[37] D. Haber,et al. Circulating tumor cells: approaches to isolation and characterization , 2011, The Journal of cell biology.
[38] Susan M. Chang,et al. Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[39] M. Klagsbrun,et al. A new perspective on tumor endothelial cells: unexpected chromosome and centrosome abnormalities. , 2005, Cancer research.
[40] K. Hoang-Xuan,et al. Primary brain tumours in adults , 2003, The Lancet.
[41] J. Xu,et al. Quantified postsurgical small cell size CTCs and EpCAM+ circulating tumor stem cells with cytogenetic abnormalities in hepatocellular carcinoma patients determine cancer relapse. , 2018, Cancer letters.
[42] G. Finocchiaro,et al. Extraneural metastases in glioblastoma patients: two cases with YKL-40-positive glioblastomas and a meta-analysis of the literature. , 2016, Neurosurgical review.